$USDC Signed into law in 2025, the act empowers the Centers for Medicare & Medicaid Services (CMS) to grant temporary coverage for innovative medical devices approved by the FDA.

This ensures quicker patient access to life-saving treatments while gathering real-world evidence on their effectiveness.

The GENIUS Act addresses delays that previously hindered adoption of advanced technologies.